[Resveratrol Inhibits T-acute Lymphoblastic Leukemia in Mice by Regulating Notch1 Signaling Pathway]

Xiao-Fei Li1, Fang Cui2, Fei Liu1

  • 1Department of Clinical Laboratory Examination, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China.

PubMed
Abstract

Insights

Resveratrol demonstrated anti-leukemia effects in T-acute lymphoblastic leukemia (T-ALL) mice by inhibiting the Notch1 signaling pathway. This natural compound reversed key indicators of leukemia progression, offering potential therapeutic benefits.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Context:

  • T-acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy.
  • The Notch1 signaling pathway is frequently implicated in T-ALL pathogenesis.
  • Resveratrol, a natural polyphenol, has shown potential anti-cancer properties.

Purpose:

  • To investigate the therapeutic effect of resveratrol on T-ALL in a mouse model.
  • To elucidate the underlying mechanism of resveratrol's action, focusing on the Notch1 signaling pathway.

Summary:

  • Resveratrol administration significantly reduced leukemia cell percentages in peripheral blood and spleen.
  • Key markers of T-ALL progression, including Notch1, Hes-1, c-Myc, and miR-19b, were downregulated by resveratrol.
  • Conversely, PTEN expression was upregulated by resveratrol, indicating pathway modulation.

Impact:

  • Resveratrol exhibits anti-leukemic activity against T-ALL in vivo.
  • Inhibition of the Notch1 signaling pathway is a potential mechanism for resveratrol's anti-TALL effects.
  • These findings suggest resveratrol as a promising candidate for T-ALL therapy.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K